Paolo A Ascierto Selected Research

Paolo A Ascierto Research Topics

Disease

291	Melanoma (Melanoma, Malignant) 04/2024 - 03/2003
148	Neoplasms (Cancer) 02/2024 - 01/2004
31	Neoplasm Metastasis (Metastasis) 03/2024 - 04/2006
24	Disease Progression 01/2023 - 11/2006
13	Brain Neoplasms (Brain Tumor) 01/2024 - 05/2012
8	Exanthema (Rash) 10/2023 - 03/2013
8	Fatigue 01/2023 - 01/2015
6	Skin Neoplasms (Skin Cancer) 02/2024 - 01/2013
6	COVID-19 03/2023 - 08/2021
6	Colitis 01/2021 - 05/2015
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 06/2016
5	Fever (Fevers) 01/2023 - 09/2016
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2022 - 03/2014
5	Hypertension (High Blood Pressure) 11/2022 - 01/2017
5	Pneumonia (Pneumonitis) 01/2022 - 08/2015
5	Body Weight (Weight, Body) 10/2019 - 01/2015
5	Neutropenia 01/2017 - 11/2012
4	Nausea 10/2023 - 01/2015
4	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 05/2010
4	Basal Cell Carcinoma (Rodent Ulcer) 12/2022 - 01/2015
4	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
4	Arthralgia (Joint Pain) 01/2020 - 01/2018
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 07/2016
3	Pain (Aches) 02/2024 - 06/2012
3	Uveal melanoma 01/2023 - 01/2017
3	Microsatellite Instability 01/2022 - 01/2020
3	Lymphatic Metastasis 11/2020 - 05/2015
3	Colonic Neoplasms (Colon Cancer) 11/2020 - 01/2018
3	Myalgia 10/2018 - 08/2015
3	Keratoacanthoma 01/2018 - 03/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 10/2017 - 06/2016
2	Cytokine Release Syndrome 12/2023 - 03/2023
2	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2023
2	Diarrhea 10/2023 - 01/2022
2	Dermatitis 10/2023 - 03/2013
2	Kidney Neoplasms (Kidney Cancer) 01/2023 - 08/2014

Drug/Important Bio-Agent (IBA)

79	IpilimumabIBA 01/2024 - 07/2011
59	NivolumabIBA 02/2024 - 12/2014
52	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2014
51	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2024 - 07/2012
47	VemurafenibIBA 04/2024 - 05/2012
45	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2006
43	pembrolizumabIBA 03/2024 - 02/2015
23	dabrafenibIBA 01/2023 - 05/2012
23	cobimetinibIBA 01/2023 - 07/2012
22	binimetinibIBA 04/2024 - 03/2013
18	encorafenibIBA 04/2024 - 07/2015
16	LigandsIBA 01/2023 - 07/2012
15	trametinibIBA 10/2023 - 03/2014
14	AntibodiesIBA 01/2024 - 10/2010
13	Monoclonal AntibodiesIBA 01/2022 - 11/2011
11	Dacarbazine (DIC)FDA LinkGeneric 11/2020 - 03/2014
10	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2023 - 01/2018
10	B7-H1 AntigenIBA 01/2023 - 10/2017
9	Mitogen-Activated Protein KinasesIBA 10/2022 - 11/2015
8	atezolizumabIBA 01/2023 - 01/2017
8	AntigensIBA 10/2022 - 10/2010
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2005
7	Creatine Kinase (Creatine Phosphokinase)IBA 10/2023 - 03/2013
7	CytokinesIBA 03/2023 - 01/2016
7	InterferonsIBA 01/2021 - 10/2008
6	durvalumabIBA 01/2023 - 01/2017
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2004
5	Lipase (Acid Lipase)FDA Link 10/2023 - 11/2012
5	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2018
5	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 01/2019
5	Programmed Cell Death 1 ReceptorIBA 01/2022 - 11/2018
5	Alanine Transaminase (SGPT)IBA 01/2021 - 04/2015
4	relatlimabIBA 10/2023 - 01/2022
4	Chimeric Antigen ReceptorsIBA 01/2023 - 11/2016
4	VaccinesIBA 01/2023 - 07/2012
4	spartalizumabIBA 01/2022 - 10/2020
4	Interleukin-2 (IL2)IBA 01/2021 - 04/2010
4	Proto-Oncogene Proteins B-rafIBA 01/2020 - 04/2014
3	tebentafuspIBA 01/2024 - 01/2023
3	bempegaldesleukinIBA 10/2023 - 10/2020
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2015
3	CTLA-4 AntigenIBA 01/2023 - 07/2015
3	EnzymesIBA 01/2022 - 10/2005
3	Circulating Tumor DNAIBA 01/2022 - 11/2018
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020 - 03/2003
3	PlatinumIBA 01/2019 - 07/2016
3	HhAntag691IBA 12/2018 - 01/2015
3	Chemokine ReceptorsIBA 11/2017 - 04/2006
3	Interferon-alpha (Interferon Alfa)IBA 08/2014 - 08/2010
3	Arginine (L-Arginine)FDA Link 06/2011 - 10/2005
2	Bispecific AntibodiesIBA 12/2023 - 10/2022
2	tremelimumabIBA 01/2023 - 11/2011
2	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 01/2023
2	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2021

Therapy/Procedure

161	Therapeutics 03/2024 - 01/2006
97	Immunotherapy 04/2024 - 07/2011
26	Drug Therapy (Chemotherapy) 01/2023 - 05/2012
10	Neoadjuvant Therapy 01/2023 - 06/2012
7	Radiotherapy 04/2021 - 05/2012
5	Retreatment 01/2023 - 01/2014
5	Lymph Node Excision (Lymph Node Dissection) 10/2022 - 01/2018
5	Biological Therapy 08/2014 - 06/2010
4	Precision Medicine 01/2022 - 11/2016
3	Aftercare (After-Treatment) 05/2023 - 01/2018